Welcome to LookChem.com Sign In|Join Free
  • or
2,3'-anhydro-2'-deoxy-5'-O-benzoyl-5-(E)-bromovinyluridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1006597-31-4

Post Buying Request

1006597-31-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1006597-31-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1006597-31-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,6,5,9 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1006597-31:
(9*1)+(8*0)+(7*0)+(6*6)+(5*5)+(4*9)+(3*7)+(2*3)+(1*1)=134
134 % 10 = 4
So 1006597-31-4 is a valid CAS Registry Number.

1006597-31-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3'-anhydro-2'-deoxy-5'-O-benzoyl-5-(E)-bromovinyluridine

1.2 Other means of identification

Product number -
Other names 2,3'-anhydro-5'-O-benzoyl-2'-deoxy-5-(E)-bromovinyluridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1006597-31-4 SDS

1006597-31-4Relevant academic research and scientific papers

NUCLEOSIDES FOR SUPPRESSING OR REDUCING THE DEVELOPMENT OF RESISTANCE IN CYTOSTATIC THERAPY

-

Page/Page column 3, (2010/09/17)

The invention relates to special nucleosides, for example, a nucleoside of the formula I, wherein R1-R5 are as described herein, and also to drugs which contain these nucleosides. Furthermore, the invention relates to the use of such nucleosides in a method for suppressing or reducing the formation of resistance in the case of cytostatic treatment of a cancer patient.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1006597-31-4